Drug firm Indoco Remedies on Monday said the UK health regulator has issued two observations after inspection of its sterile manufacturing facility at Verna, Goa.
The inspection by UK health regulator, MHRA were held from September 16-20, 2019 and resulted in 2 observations, Indoco Remedies said in a regulatory filing.
The company did not elaborate on the nature of the observations.
The Sterile manufacturing site is expected to receive the European Union Good manufacturing practice (EUGMP) certification soon, following this recent inspection, the company added.
Shares of Indoco Remedies were trading 1.45 per cent higher at Rs 160.50 apiece on the BSE.
Disclaimer: No Business Standard Journalist was involved in creation of this content
You’ve reached your limit of {{free_limit}} free articles this month.
Subscribe now for unlimited access.
Already subscribed? Log in
Subscribe to read the full story →
Smart Quarterly
₹900
3 Months
₹300/Month
Smart Essential
₹2,700
1 Year
₹225/Month
Super Saver
₹3,900
2 Years
₹162/Month
Renews automatically, cancel anytime
Here’s what’s included in our digital subscription plans
Exclusive premium stories online
Over 30 premium stories daily, handpicked by our editors
Complimentary Access to The New York Times
News, Games, Cooking, Audio, Wirecutter & The Athletic
Business Standard Epaper
Digital replica of our daily newspaper — with options to read, save, and share
Curated Newsletters
Insights on markets, finance, politics, tech, and more delivered to your inbox
Market Analysis & Investment Insights
In-depth market analysis & insights with access to The Smart Investor
Archives
Repository of articles and publications dating back to 1997
Ad-free Reading
Uninterrupted reading experience with no advertisements
Seamless Access Across All Devices
Access Business Standard across devices — mobile, tablet, or PC, via web or app